Company / Working Capital
Avanos Medical, Inc. Working Capital History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital
$190.2M
FY2025
5-year range
$190.2M / $433.1M
FY2021-FY2025
Trend
-16.4%
vs FY2024
Sector context
#118 of 165
Health Care
What the data says
At $190M, Avanos Medical, Inc.'s working capital ranks #118 of 165 in the Health Care sector. Working Capital has declined for 3 consecutive years, from $433M in FY2022 to $190M in FY2025.
Based on SEC 10-K filings.
$190M in FY2025 with a 5-year CAGR of -8.8%.
Declined from $252M to $190M over the past 2 years.
Health Care sector context is included.
Working Capital over time
Growth rates
- 3-Year CAGR
- -24.0%
- 5-Year CAGR
- -8.8%
- 10-Year CAGR
- -
Sector benchmark
#118 of 165 in Health CareTop 72% of 165This company $190.2M Sector average $836.2M
▼
-77.3% below sector average
Key checks
Key Insights
- Avanos Medical, Inc.'s working capital has declined for 3 consecutive years.
- 5-year CAGR of -8.8%, indicating a declining trend.
- In FY2025, working capital decreased 16.4% year-over-year.
- Ranks #118 out of 165 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 1.09 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working CapitalValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $190.2M | -16.4% |
| FY2024 | $227.5M | -9.9% |
| FY2023 | $252.4M | -41.7% |
| FY2022 | $433.1M | +50.2% |
| FY2021 | $288.4M | -4.2% |
| FY2020 | $300.9M | -7.7% |
| FY2019 | $326.0M | -27.4% |
| FY2018 | $449.3M | -41.7% |
| FY2017 | $770.9M | +186.5% |
| FY2016 | $269.1M | -25.4% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026